GlassScriptPhysician profile
Timothy D Daniel
NPI 1770679573
$78,092.71
in general payments reported to CMS, 2019-2025
46 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,302 · 2021: $7,396 · 2022: $8,151 · 2023: $17K · 2024: $7,104 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $8,072 · Travel and Lodging: $3,796 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150 · Education: $50.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,500.00 |
| Food and Beverage | $8,072.42 |
| Travel and Lodging | $3,795.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
| Education | $50.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $58,910.29 | 2019-2025 | Freestyle Libre 3, Freestyle Libre |
| Sanofi-Aventis U.S. LLC | $7,970.95 | 2019-2025 | |
| Novo Nordisk INC | $3,712.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $1,182.76 | 2021-2025 | |
| Amarin Pharma, INC. | $833.55 | 2019-2022 | |
| Lilly USA, LLC | $714.69 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $515.40 | 2021-2025 | Linzess, Viberzi, Qulipta |
| Corcept Therapeutics | $438.89 | 2019-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $435.34 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Musculoskeletal Transplant Foundation INC. | $284.90 | 2019-2025 | |
| Amgen INC. | $281.22 | 2021-2025 | Otezla, Repatha, Repatha |
| Madrigal Pharmaceuticals | $265.71 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $164.13 | 2020-2023 | Verquvo, Steglujan, Steglatro |
| Insulet Corporation | $163.40 | 2019-2024 | Omnipod |
| Medtronic, INC. | $162.31 | 2022-2025 | Venaseal, Corevalve Evolut R |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $162.00 | 2025 | Cequr Simplicity |
| Janssen Pharmaceuticals, INC | $161.94 | 2019-2025 | Spravato |
| Exact Sciences Corporation | $153.23 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $142.89 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.14 | 2022 | |
| Tandem Diabetes Care, INC. | $125.00 | 2020 | |
| Embecta Corp. | $113.85 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Glaxosmithkline, LLC. | $106.48 | 2021-2025 | Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $105.80 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.33 | 2019-2024 | Xifaxan |
| Abiomed | $91.68 | 2025 | |
| Mylan Specialty L.P. | $75.07 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.36 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Dexcom, INC. | $66.76 | 2019-2020 | |
| Becton, Dickinson and Company | $43.92 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $42.63 | 2023 | Quviviq |
| Eisai INC. | $34.52 | 2021-2025 | |
| Inari Medical, INC. | $34.23 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ascendis Pharma Endocrinology INC | $28.50 | 2025 | Yorvipath |
| Astellas Pharma US INC | $27.82 | 2024 | Veozah |
| Axsome Therapeutics, INC. | $27.20 | 2025 | Symbravo |
| Companion Medical, INC. | $26.97 | 2019 | |
| Phathom Pharmaceuticals, INC. | $26.79 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $25.65 | 2023 | Trintellix |
| Edwards Lifesciences Corporation | $23.68 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Mannkind Corporation | $22.50 | 2019 | |
| Currax Pharmaceuticals LLC | $22.22 | 2021 | |
| Intuity Medical INC | $19.30 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ibsa Pharma INC. | $17.92 | 2025 | Tirosint, Flector, Licart |
| Medtronic Minimed, INC. | $17.84 | 2020 | |
| Tactile Systems Technology INC | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.